October 18, 2023
Company Description: Monument Tx is a clinical stage neuroscience-specialist drug development company. Taking our cue from oncology, we aim to radically reduce drug development timeframes, and increase success rates, by applying a stratified medicine approach to neuroscience. We use proprietary digital biomarkers to detect subgroups of patients with common underlying biological abnormalities. We then treat these patients with proprietary reformulations of drugs that provide strong IP and product differentiation but an accelerated route to market.
CEO/Top Company Official
Dr Jenny Barnett
Lead Product in Development
MT1988, a small molecule for the treatment of cognitive impairment in schizophrenia
Development Phase of Primary Product